Skip to main content

Shopping Cart

You're getting the VIP treatment!

Item(s) unavailable for purchase
Please review your cart. You can remove the unavailable item(s) now or we'll automatically remove it at Checkout.
itemsitem
itemsitem

Recommended For You

Loading...
  • Investigation and Stimulation of Immunity in Cancer Patients

    Edited by G. Mathe, R. Weiner ...
    Series series Medicine (R0)
    G.MATHE Institut de Cancerologie et d'Immunogenetique (INSERM et Association Claude-Bernad), H6pital Paul-Brousse and Institute Gustave-Roussy, Villejuif 20 years ago, the main, if not only object of the cancer therapist was to effect complete surgical exeresis or radiotherapeutic destruction of a local tumor, or to obtain, by means of chemotherapy, an "apparently complete regression" of a local ... Read more

    $49.49 USD

  • Nomenclature, Methodology and Results of Clinical Trials in Acute Leukemias

    Workshop held June 19 and 20, 1972 at the Centre National de la Recherche Scientifique (C.N.R.S.), France

    Series series Medicine (R0)
    Scientific and Ethical Discipline in Clinical Trials on Acute Leukemia G. MATHE Institut de Cancerologie ct d'Immunogenetique "', Hi'ipital Paul-Brousse "."", Villejuif/France Clinical research is still in an evolutionary stage. Although scientific technology was readily accepted and applied, scientific methodology has been accepted much more slowly and is very rarely properly applied. There are ... Read more

    $89.09 USD

  • Complications of Cancer Chemotherapy

    Proceedings of the Plenary Sessions of E.O.R.T.C., Paris, June 1973

    Edited by G. Mathe, R.K. Oldham ...
    Series series Medicine (R0)
    G. MATHE and R. K. OLDHAM'~ Institut de Cancerologie et d'Immunogem!tique, Hopital Paul Brousse, Villejuif Since the last war, cancer chemotherapy has been the object of very intensive and expensive research. Nevertheless, its development has been very slow, and its ultimate potential is today somewhat in doubt. In doubt because it does not cure any cancer patients except a) females carrying ... Read more

    $89.09 USD

  • Lymphoid Neoplasias II

    Clinical and Therapeutic Aspects

    Edited by G. Mathe, M. Seligmann, M. Tubiana ...
    Series series Medicine (R0)
    We have studied 24 cases of secondarily leukemic (stage V) lymphosarcoma (LS), 31 cases of "d'emblee" leukemic LS, and ten cases of lymphoid leukemic neoplasias transitional between "d'emblee" leukemic LS and chronic lymphocytic leukemia (eLL). These cases only concern the common types ofthe WHO classification ofLS, i.e., the prolymphocytic, the lymphoblastic, and the immunoblastic. Some cases ... Read more

    $89.09 USD

  • Adjuvant Therapies of Cancer

    Series series Medicine (R0)
    Transplantation of syngeneic (donor is a monozygous twin) or allogeneic (donor is an HLA-identical sibling) marrow provides the opportunity for aggressive antileukemic therapy without regard to marrow toxicity. Until 1975, marrow transplantation was carried out only after failure of all other therapy. Consequently, most patients were in advanced relapse. Six of 16 recipients of syngeneic marrow ... Read more

    $89.09 USD

  • Adjuvant Therapies and Markers of Post-Surgical Minimal Residual Disease I

    Markers and General Problems of Cancer Adjuvant Therapies

    Series series Medicine (R0)
    P. Denoix and G. Mathe Approximately 70% of cancer patients relapse after surgery before the 5th year and, in most cases, for example in breast carcinoma, they relapse still later up to the 20th year. For some considerable time, the strategy of cancer treatment has been limited to the sophistication of surgery-radiotherapy combinations that maximally decreased the incidence of local and regional ... Read more

    $89.09 USD

  • Lymphocytes, Macrophages, and Cancer

    Series series Medicine (R0)
    Fresh living Bacillus Calmette-Guerin (BeG), injected i.v. into (C57BI/ 6xDBA/2)FI mice, activated peritoneal macrophages rendering them highly cytotoxic for tumor cells in vitro. This cytotoxic activity w~s already maximal 14 days after injection of 1 mg of BCG and remained stable when 3 or 5 mg of BCG were given. At the same time spleen cells of the BCG-treat~d mice showed strongly depressed ... Read more

    $89.09 USD

  • Audiobook

    G.K. Chesterton in Vanity Fair Magazine (Unabridged)

    optional

    Unabridged

    2 hours 20 min

    Step into the roaring twenties with one of literature's most captivating minds. "G.K. Chesterton in Vanity Fair Magazine" is a collection of essays penned by the legendary author himself, exclusively for the iconic Vanity Fair. Brace yourself for witty social commentary, insightful cultural critiques, and the brilliant paradoxes that made Chesterton famous. In these pages, you'll find "The Next ... Read more

    $4.99 USD

  • International Symposium on Adriamycin

    Milan, 9th-10th September, 1971

    Series series Biomedical and Life Sciences (R0)
    The impressive advances in all branches of medical science during the first half of this century with the discovery of many chemotherapeutic or immunogenic agents gave rise to brilliant achievements in the struggle against some infectious diseases and aroused in many scientists the wishful thought that drugs for cancer therapy would, soon lead to additional great success. Notwithstanding ever ... Read more

    $89.09 USD